Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3Kγ pathway

Cardiovascular Research

Volumn 102, Issue 1, 2014, Pages 118-127

  Gayral, Stephanie ^a   Garnotel, Roselyne ^b   Castaing Berthou, Audrey ^a   Blaise, Sebastien ^b   Fougerat, Anne ^c   Berge, Elodie ^a   Montheil, Aurelie ^a   Malet, Nicole ^a   Wymann, Matthias P ^c   Maurice, Pascal ^b   Debelle, Laurent ^b   Martiny, Laurent ^b   Martinez, Laurent O ^a   Pshezhetsky, Alexey V ^d   Duca, Laurent ^b   Laffargue, Muriel ^a  

^a University Hospital of Toulouse   (France)

^b UFR Sciences Exactes et Naturelles   (France)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Atherosclerosis; Elastin peptides; Inflammation; Phosphoinositide 3 kinase

Indexed keywords

APOLIPOPROTEIN E; CARBOXYPEPTIDASE C; ELASTIN; ELASTIN DERIVED PEPTIDE; ELASTIN RECEPTOR COMPLEX; LOW DENSITY LIPOPROTEIN RECEPTOR; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PROTEIN NEU1; REACTIVE OXYGEN METABOLITE; SIALIDASE; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; ELASTIN-BINDING PROTEINS; NEU1 PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CD PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY DISEASE; ARTERY LESION; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW CELL; CELL INFILTRATION; CELL LINEAGE; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; IN VITRO STUDY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; ATHEROSCLEROSIS; DIET, ATHEROGENIC; ELASTIN; MICE, INBRED C57BL; MONOCYTES; NEURAMINIDASE; PEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, LDL; SIGNAL TRANSDUCTION;

EID: 84897012818     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt336     Document Type: Article

References (44)

1. Maurice P, Blaise S, Gayral S, Debelle L, Laffargue M, Hornebeck W et al. Elastin fragmentation and atherosclerosis progression: the elastokine concept. Trends Cardiovasc Med 2013;23:211-221.
2. Bizbiz L, Alperovitch A, Robert L. Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation to cardiovascular risk factors. The EVA study. Atherosclerosis 1997;131:73-78.
3. Robert L, Robert AM, Jacotot B. Elastin-elastase-atherosclerosis revisited. Atherosclerosis 1998;140:281-295.
4. Petersen E, Wagberg F, Angquist KA. Serum concentrations of elastin-derived peptides in patients with specific manifestationsof atherosclerotic disease. Eur J Vasc Endovasc Surg 2002;24:440-444.
5. Fulop T Jr, Larbi A, Fortun A, Robert L, Khalil A. Elastin peptides induced oxidationofLDL by phagocytic cells. Pathol Biol 2005;53:416-423.
6. Robert L, Jacob MP, Frances C, Godeau G, Hornebeck W. Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues. A review. Mech Ageing Dev 1984;28:155-166.
7. Faury G, Ristori MT, Verdetti J, Jacob MP, Robert L. Effect of elastin peptides on vascular tone. J Vasc Res 1995;32:112-119.
8. Mochizuki S, Brassart B, Hinek A. Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J Biol Chem 2002;277: 44854-44863.
9. Duca L, Blanchevoye C, Cantarelli B, Ghoneim C, Dedieu S, Delacoux F et al. The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. J Biol Chem 2007;282:12484-12491.
10. Rusciani A, Duca L, Sartelet H, Chatron-Colliet A, Bobichon H, Ploton D et al. Elastin peptides signaling relies on neuraminidase-1-dependent lactosylceramide generation. PloS one 2010;5:e14010.
11. Duca L, Lambert E, Debret R, Rothhut B, Blanchevoye C, Delacoux F et al. Elastin pep-tides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts. Mol Pharmacol 2005;67:1315-1324.
12. Wymann MP, Zvelebil M, Laffargue M. Phosphoinositide 3-kinase signalling-which way to target? Trends Pharmacol Sci 2003;24:366-376.
13. Fougerat A, Gayral S, Gourdy P, Schambourg A, Ruckle T, Schwarz MK et al. Genetic and pharmacological targetingofphosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes. Circulation 2008;117: 1310-1317.
14. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000;287: 1049-1053.
15. Laffargue M, Calvez R, Finan P, Trifilieff A, Barbier M, Altruda F et al. Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity 2002;16: 441-451.
16. Seyrantepe V, Hinek A, Peng J, Fedjaev M, Ernest S, Kadota Y et al. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation 2008;117:1973-1981.
17. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987;68:231-240.
18. Hinek A, Wrenn DS, Mecham RP, Barondes SH. The elastin receptor: a galactoside-binding protein. Science 1988;239:1539-1541.
19. Mecham RP, Hinek A, Entwistle R, Wrenn DS, Griffin GL, Senior RM. Elastin binds to a multifunctional 67-kilodalton peripheral membrane protein. Biochemistry 1989;28: 3716-3722.
20. Blanchevoye C, Floquet N, Scandolera A, Baud S, Maurice P, Bocquet O et al. Interaction between the elastin peptide VGVAPG and human elastin binding protein. J Biol Chem 2013;288:1317-1328.
21. Brassart B, Fuchs P, Huet E, Alix AJ, Wallach J, Tamburro AM et al. Conformational dependence of collagenase (matrix m et al loproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem 2001;276:5222-5227.
22. Senior RM, Griffin GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest 1980;66:859-862.
23. 2+ mobilization, stimulation of respiratory burst and enzyme secretion. Biochem Biophys Res Commun 1986;141:92-98.
24. Fulop T Jr, Jacob MP, Khalil A, Wallach J, Robert L. Biological effects of elastin peptides. Pathol Biol 1998;46:497-506.
25. Hinek A, Pshezhetsky AV, von Itzstein M, Starcher B. Lysosomal sialidase (neuraminidase-1) istargetedtothe cell surfaceinamultiprotein complex that facilitates elastic fiber assembly. J Biol Chem 2006;281:3698-3710.
26. Hornebeck W, Emonard H. The cell-elastin-elastase(s) interacting triade directs elasto-lysis. Front Biosci (Landmark Ed) 2011;16:707-722.
27. Aikawa E, Aikawa M, Libby P, Figueiredo JL, Rusanescu G, Iwamoto Y et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 2009;119:1785-1794.
28. Seyrantepe V, Iannello A, Liang F, Kanshin E, Jayanth P, Samarani S et al. Regulation of phagocytosis in macrophages by neuraminidase 1. J Biol Chem 2010;285:206-215.
29. Fulop T, Khalil A, Larbi A. The role of elastinpeptides in modulating the immune response in aging and age-related diseases. Pathol Biol 2011;60:28-33.
30. Baydanoff S, Nicoloff G, Alexiev C. Age-related changesin the level of circulating elastin-derived peptides in serum from normal and atherosclerotic subjects. Atherosclerosis 1987;66:163-168.
31. Blaise S, Romier B, Kawecki C, Ghirardi M, Rabenoelina F, Baud S et al. Elastin-derived peptides, new regulators of insulin resistance development in mice. Diabetes 2013;62: 3807-3816.
32. Pocza P, Suli-Vargha H, Darvas Z, Falus A. Locally generatedVGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor. Int JCancer 2008; 122:1972-1980.
33. Duca L, Floquet N, Alix AJ, Haye B, Debelle L. Elastinasamatrikine. Crit Rev Oncol Hematol 2004;49:235-244.
34. Chang JD, Sukhova GK, Libby P, Schvartz E, Lichtenstein AH, Field SJet al. Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis. Proc Natl Acad Sci USA 2007;104:8077-8082.
35. Anzinger JJ, Chang J, Xu Q, Barthwal MK, Bohnacker T, Wymann MP et al. Murine bone marrow-derived macrophages differentiated with GM-CSF become foam cells by PI3Kgamma-dependentfluid-phase pinocytosis ofnative LDL. J Lipid Res 2012;53:34-42.
36. Fougerat A, Gayral S, Malet N, Briand-Mesange F, Breton-Douillon M, Laffargue M. Phos-phoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis? Clin Sci (Lond) 2009;116:791-804.
37. Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000;287:1040-1046.
38. Hance KA, Tataria M, Ziporin SJ, Lee JK, Thompson RW. Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor. J Vasc Surg 2002;35:254-261.
39. Iwabuchi K, Prinetti A, Sonnino S, Mauri L, Kobayashi T, Ishii K et al. Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils. Glycoconj J 2008;25:357-374.
40. Iwabuchi K, Nagaoka I. Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood 2002;100:1454-1464.
41. Debret R, Antonicelli F, Theill A, Hornebeck W, Bernard P, Guenounou M et al. Elastin-derived peptides induce a T-helper type 1 polarization of human blood lymphocytes. Arterioscler Thromb Vasc Biol 2005;25:1353-1358.
42. Lahoute C, Herbin O, Mallat Z, Tedgui A. Adaptive immunity inatherosclerosis: mechanisms and future therapeutic targets. Nat Rev Cardiol 2011;8:348-358.
43. van der Horst GT, Galjart NJ, d'Azzo A, Galjaard H, Verheijen FW. Identification and in vitro reconstitution of lysosomal neuraminidase from human placenta. J Biol Chem 1989; 264:1317-1322.
44. Pshezhetsky AV, Hinek A. Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors. Glycoconj J 2011;28:441-452.